Possible Risks Associated With Valproate Treatment of AIDS-Related Mania
J Clin Psychiatry 1998;59:317-317 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Sir: Recently, RachBeisel and Weintraub contributed further to the literature on the usefulness of valproate for treating AIDS-related mania. Contrary to current trends, they apparently prescribed valproic acid rather than divalproex sodium— the former being less expensive, but generally less well tolerated. Given the likelihood of preexisting gastrointestinal symptoms in this population, better tolerability rather than lower cost might make divalproex sodium the preferred preparation.